Option chain shows key data for Conduit Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Conduit Pharmaceuticals.

Conduit Pharmaceuticals (NASDAQ:CDT) Stock, Option Chain

Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Analyst strongly recommends investors to buy Zomato stock

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

BILL

DOCS

FARM

NKLA

Dow Dips 400 Points; US Adds Fewer Than Expected Jobs

Nasdaq index

AMZN

MGOL

Nasdaq Gains Over 50 Points; Amazon Issues Weak Outlook

twilio shutter3

Pre-Market Outlook

Movers

ACON

ACTG

ALUR

BTAI

CNTA

DALN

DWTX

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals Inc

Infinitii Ai Inc

CDT Environmental Technology Investment Holdings Limited - ordinary shares

CDT Environmental Technology Investment Holdings Ltd

CDTI ADVANCED MATERIALS by CDTI Advanced Materials, Inc.

CDTi Advanced Materials Inc

Cidara Therapeutics Inc

Legal

Press Releases

General

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Health Care

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Financing

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Conduit Progresses Phase II of its AI Initiative with Sarborg

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Akoya Biosciences

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Bionano Genomics

Codexis

Champions Oncology

Harvard Bioscience

Lifecore Biomedical

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Cable Design

Comments

Conduit Pharmaceuticals

Conduit Pharmaceuticals (CDT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga